FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4220666650> ?p ?o ?g. }

• W4220666650 endingPage "1670" @default.
• W4220666650 startingPage "1658" @default.
• W4220666650 abstract "Abstract Objective Numerous predictive scores have been developed to help determine which patients with epilepsy or seizures of unknown etiology should undergo neural antibody testing. However, their diagnostic advantage compared to only performing testing in patients with “obvious” indications (e.g., broader features of autoimmune encephalitis, characteristic seizure semiologies) requires further study. We aimed to develop a checklist that identifies patients who have “obvious” indications for neural antibody testing and to compare its diagnostic performance to predictive scores. Methods We developed the “Obvious” indications for Neural antibody testing in Epilepsy or Seizures (ONES) checklist through literature review. We then retrospectively reviewed patients who underwent neural antibody testing for epilepsy or seizures at our center between March 2019 and January 2021, to determine and compare the sensitivity and specificity of the ONES checklist to the recently proposed Antibody Prevalence in Epilepsy and Encephalopathy (APE2)/Antibodies Contributing to Focal Epilepsy Signs and Symptoms (ACES) reflex score. Results One‐hundred seventy patients who underwent neural antibody testing for epilepsy or seizures were identified. Seventy‐four of 170 (43.5%) with a known etiology were excluded from sensitivity/specificity analyses; none had a true‐positive neural antibody. Of the 96 patients with an unknown etiology, 14 (15%) had a true‐positive neural antibody. The proportion of false‐positives was significantly higher among patients with a known etiology (3/3, 100%) compared to an unknown etiology (2/16, 13%; p = .01). There was no significant difference of the APE2/ACES reflex score compared to the ONES checklist with regard to sensitivity (93% for both, p > .99) or specificity (71% vs. 78%, p = .18) for true‐positive neural antibodies. Significance Compared to only performing neural antibody testing in patients with epilepsy or seizures of unknown etiology who have “obvious” indications, predictive scores confer no clear diagnostic advantage. Prespecified definitions of what constitutes a true‐positive neural antibody is required in future studies to avoid false‐positives that can confound results." @default.
• W4220666650 created "2022-04-03" @default.
• W4220666650 creator A5030006733 @default.
• W4220666650 creator A5055369067 @default.
• W4220666650 creator A5073933196 @default.
• W4220666650 creator A5075224905 @default.
• W4220666650 creator A5088697266 @default.
• W4220666650 date "2022-04-18" @default.
• W4220666650 modified "2023-10-10" @default.
• W4220666650 title "“Obvious” indications for Neural antibody testing in Epilepsy or Seizures: The ONES checklist" @default.
• W4220666650 cites W1992506118 @default.
• W4220666650 cites W2014778415 @default.
• W4220666650 cites W2077891398 @default.
• W4220666650 cites W2103644035 @default.
• W4220666650 cites W2103856324 @default.
• W4220666650 cites W2159439874 @default.
• W4220666650 cites W2280783985 @default.
• W4220666650 cites W2298192377 @default.
• W4220666650 cites W2519077753 @default.
• W4220666650 cites W2544465965 @default.
• W4220666650 cites W2578761578 @default.
• W4220666650 cites W2586972945 @default.
• W4220666650 cites W2588791250 @default.
• W4220666650 cites W2592509339 @default.
• W4220666650 cites W2617258020 @default.
• W4220666650 cites W2783144549 @default.
• W4220666650 cites W2785100978 @default.
• W4220666650 cites W2800596677 @default.
• W4220666650 cites W2884103526 @default.
• W4220666650 cites W2886031194 @default.
• W4220666650 cites W2910735087 @default.
• W4220666650 cites W2913472312 @default.
• W4220666650 cites W2914944710 @default.
• W4220666650 cites W2931699176 @default.
• W4220666650 cites W2956073307 @default.
• W4220666650 cites W2993538780 @default.
• W4220666650 cites W3009841438 @default.
• W4220666650 cites W3011060062 @default.
• W4220666650 cites W3031832795 @default.
• W4220666650 cites W3034212049 @default.
• W4220666650 cites W3042051377 @default.
• W4220666650 cites W3042620623 @default.
• W4220666650 cites W3082563548 @default.
• W4220666650 cites W3101532146 @default.
• W4220666650 cites W3109423028 @default.
• W4220666650 cites W3119687660 @default.
• W4220666650 cites W3121207762 @default.
• W4220666650 cites W3127747976 @default.
• W4220666650 cites W3159467683 @default.
• W4220666650 cites W3159630391 @default.
• W4220666650 cites W3159903727 @default.
• W4220666650 cites W3163926470 @default.
• W4220666650 cites W3200252510 @default.
• W4220666650 cites W4200225794 @default.
• W4220666650 cites W4206073738 @default.
• W4220666650 cites W4206135968 @default.
• W4220666650 cites W4220666650 @default.
• W4220666650 cites W4220761596 @default.
• W4220666650 doi "https://doi.org/10.1111/epi.17238" @default.
• W4220666650 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35340020" @default.
• W4220666650 hasPublicationYear "2022" @default.
• W4220666650 type Work @default.
• W4220666650 citedByCount "8" @default.
• W4220666650 countsByYear W42206666502022 @default.
• W4220666650 countsByYear W42206666502023 @default.
• W4220666650 crossrefType "journal-article" @default.
• W4220666650 hasAuthorship W4220666650A5030006733 @default.
• W4220666650 hasAuthorship W4220666650A5055369067 @default.
• W4220666650 hasAuthorship W4220666650A5073933196 @default.
• W4220666650 hasAuthorship W4220666650A5075224905 @default.
• W4220666650 hasAuthorship W4220666650A5088697266 @default.
• W4220666650 hasBestOaLocation W42206666502 @default.
• W4220666650 hasConcept C118552586 @default.
• W4220666650 hasConcept C119857082 @default.
• W4220666650 hasConcept C126322002 @default.
• W4220666650 hasConcept C137627325 @default.
• W4220666650 hasConcept C15744967 @default.
• W4220666650 hasConcept C180747234 @default.
• W4220666650 hasConcept C187212893 @default.
• W4220666650 hasConcept C2778186239 @default.
• W4220666650 hasConcept C2779356329 @default.
• W4220666650 hasConcept C41008148 @default.
• W4220666650 hasConcept C64869954 @default.
• W4220666650 hasConcept C71924100 @default.
• W4220666650 hasConceptScore W4220666650C118552586 @default.
• W4220666650 hasConceptScore W4220666650C119857082 @default.
• W4220666650 hasConceptScore W4220666650C126322002 @default.
• W4220666650 hasConceptScore W4220666650C137627325 @default.
• W4220666650 hasConceptScore W4220666650C15744967 @default.
• W4220666650 hasConceptScore W4220666650C180747234 @default.
• W4220666650 hasConceptScore W4220666650C187212893 @default.
• W4220666650 hasConceptScore W4220666650C2778186239 @default.
• W4220666650 hasConceptScore W4220666650C2779356329 @default.
• W4220666650 hasConceptScore W4220666650C41008148 @default.
• W4220666650 hasConceptScore W4220666650C64869954 @default.
• W4220666650 hasConceptScore W4220666650C71924100 @default.
• W4220666650 hasIssue "7" @default.
• W4220666650 hasLocation W42206666501 @default.

• next